Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations

Lu Yao(Tianjin Medical University Cancer Institute and Hospital), Yuntao Xie(Peking University), Yingjian He(Peking University), Jie Sun(Ministry of Education), Juan Zhang(Central South University), Jinfeng Li(Hebei Medical University), Zhaoqing Fan(Daqing Oilfield General Hospital), Tianfeng Wang(Harbin Medical University), Tao Ouyang(Ministry of Education), Tie Fan(Ministry of Education), Benyao Lin(Ministry of Education)
Breast Cancer Research and Treatment
March 31, 2016
10.1007/s10549-016-3766-3
Cited by 39

Related Papers

Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
|Clinical Cancer Research|2017|272
Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration
|Journal of Medicinal Chemistry|2013|221
Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
|Journal of Clinical Oncology|2009|218
A Systematic Review of Histone Lysine‐Specific Demethylase 1 and Its Inhibitors
|Medicinal Research Reviews|2015|181
Carotenoid and superoxide dismutase are the most effective antioxidants participating in ROS scavenging in phenanthrene accumulated wheat leaf
|Chemosphere|2018|137